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Mersalyl inhibits H+ transport via the uncoupling protein (UP) in brown adipose tissue (BAT) mitochon- 
dria estimated as swelling in potassium acetate (K, 67 PM) or as valinomycin-induced H+ extrusion in &SO4 
(K, 55 PM) and KCl. The swelling in KC1 is depressed only slightly. Some other SH-reagents (p-hydroxy- 
mercuribenzoate, 5,5’-dithiobis(2nitrobenzoate) and thiolyte DB), but not hydrophobic reagents (N-ethyl- 
maleimide and eosin-5-maleimide), exhibit analogous inhibition. Thus an essential SH-group localized at 
the water-accessible cytosohc surface of UP was found to be involved in H+ transport via UP but not in 
Cl- transport. 
Mersalyl; Uncoupling protein; Sulfhydryl reagent; H+ transport; Sulthydryl group; (Brown-fat mitochondria) 
1. INTRODUCTION 
The uncoupling protein of brown adipose tissue 
mitochondria forms an H+ transport pathway 
across the inner membrane. It allows H+ short- 
circuiting of respiration-generated protonmotive 
force and results in heat production in this tissue 
during acute thermogenesis [l-3]. H+ transport is 
inhibited after binding purine nucleoside di- and 
triphosphates to a site localized at the outer surface 
of UP [4-81 and activated after specific interaction 
of UP with free fatty acid [S-lo]. All these proper- 
ties were confirmed also in reconstitution ex- 
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periments [5-81. In addition, UP forms a Cl- 
transport pathway [7,8], probably different from 
the H+ transport pathway [l 11, which is regulated 
only by purine nucleotides [7,8,11]. In its natural 
state UP is a dimer consisting of two identical 
subunits with M, 33 000 which bear one nucleotide- 
binding site [4]. Each subunit contains 306 amino 
acid residues, the sequence of which was deter- 
mined directly [12] or derived from cDNA coding 
the protein [ 131. 
No artificial inhibitor of H+ or Cl- transport via 
UP has yet been found. The suggestion that DCCD 
specifically inhibits Cl- transport [14] was ques- 
tioned (Jeiek, P., unpublished and [S,lS]), hence 
any characterization of the transport pathway 
formed by UP is still lacking. 
This work reports for the first time the inhibi- 
tion of H+ transport via UP by hydrophilic SH- 
reagents, which do not affect Cl- transport via 
UP. It suggests the participation of SH-group(s) in 
the H+ translocation mechanism and thus places 
the uncoupling protein into the large group of 
mitochondrial ion-transport carriers possessing 
SH-groups essential for transport. 
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2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
Valinomycin, oligomycin, rotenone, antimycin 
A, nigericin, GDP-Na salt, BSA, mersalyl, DTNB, 
PMB, NEM and dithioerythritol were purchased 
from Sigma. Thiolyte DB was obtained from 
Calbiochem and EMA from Molecular Probes. All 
other chemicals were of analytical grade. 
BAT mitochondria from hamsters adapted to 
the cold (S’C) for at least 3 weeks were prepared 
according to Hittelman [16]. The protein content 
was estimated by the method of Lowry et al. [17] 
using BSA as a standard. 
The impermeant reversible SH-reagent mersalyl 
inhibits transport via various metabolite carriers in 
mitochondria [22-241. It indicates a broad par- 
ticipation of essential SH-groups in the transloca- 
tion of various substrates. SH-groups attacked by 
mersalyl are mostly exposed to the water-accessible 
parts of carrier proteins at the outer surface of the 
membrane [22-241. 
H+ transport via UP was estimated either in- 
directly as valinomycin-induced swelling in 
150 mM K-acetate, 5 mM K-Tes, pH 6.9, or 
directly as valinomycin-induced H+ extrusion in 
110 mM KzS04 or 150 mM KC1 with 2 mM K-Tes 
(pH 6.9). All media contained 8 PM rotenone, 
2.3 PM oligomycin and 1 PM antimycin A. 
Transport was initiated by the addition of 
valinomycin (1 pg. (mg protein))‘) usually 20 s 
after addition of BAT mitochondria to the 
medium. The accompanying swelling in KC1 was 
followed simultaneously with H+ extrusion in the 
apparatus described elsewhere [ 11,181. Initial rates 
of swelling and H+ extrusion were calculated as 
differences of rates before and after valinomycin 
addition and were exposed in % ZO - min-’ (where 
ZO is the initial light scattering intensity of the 
mitochondrial sample) and in nmol H+. min-’ - 
(mg protein)- ‘, respectively [11,181. 
As shown in fig. 1, mersalyl also decreases the in- 
itial rate of swelling of BAT mitochondria in K- 
acetate, induced by valinomycin, as well as the in- 
itial rate of valinomycin-induced H+ extrusion in 
KzS04. These H+ fluxes were shown to be 
mediated by UP [ 11,251 as indicated also in fig. 1, 
showing GDP inhibition. The effect of mersalyl 
can be reversed by the addition of cysteine after 
(fig.1) or before (fig.2) valinomycin. Thus two in- 
dependent methods document he reversible inhibi- 
tion by mersalyl of H+ transport via UP. 
Because mersalyl was shown to induce K+ 
permeability [26,27] and to penetrate the mem- 
brane at higher concentrations [28], one should 
(a) 
“al 
(b) 
The intactness of mitochondria was checked by 
following ion transport mediated exclusively by 
added ionophores (1 kg - (mg protein)-‘) in the 
presence of 200pM GDP, which fully blocks the 
transport via UP. Thus nigericin-induced swelling 
in K-acetate, nigericin-induced H+ extrusion in 
KC1 or KzS04 and TBT-mediated swelling in the 
presence of valinomycin and CCCP (5 nmol . (mg 
protein)-‘) were used as control systems. Any 
decrease of transport rates in these systems was 
taken as an indication of smoothing of ion gra- 
dients or another membrane damage resulting 
from side effects of the modifiers. 
SH-reagents were added either directly to the 
medium 20 s before valinomycin, or modification 
procedures were used as in [19] for DTNB and 
analogously for thiolyte DB and as in [20,21] for 
NEM and EMA. 
L ,064 10 I 
Fig. 1. (a) The effect of mersalyl on valinomycin-induced 
swelling of BAT mitochondria (1 mg protein *ml-‘) in 
150 mM K-acetate, 5 mM K-Tes (pH 6.9) including 
oligomycin, rotenone and antimycin A. The inhibition 
by 210 PM GDP is also shown. The record in the middle 
shows the reversibility of mersalyl inhibition after 
addition of cysteine to mM. (b) The effect of 175 pM 
mersalyl on valinomycin-induced H+ extrusion in 
110 mM K2S04, 2 mM K-Tes (pH 6.9) and the above- 
mentioned inhibitors. 1 mg protein.ml-r of BAT 
mitochondria was used. Initial rate values are indicated 
at the curves. 
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Fig.2. Concentration dependence of mersalyl inhibition. 
(m) Valinomycin-induced H+ extrusion in KzS04; (A) 
valinomycin-induced swelling of BAT mitochondria in 
K-acetate in the absence of cysteine; (0) in the presence 
of 3.5 mM cysteine; (0) nigericin-induced swelling of 
BAT mitochondria in K-acetate. All points represent he 
mean values of 4-6 experiments (= , A) or 2-3 
experiments (o,o). The bars indicate SD. When the 
bars are omitted, SD was less than the symbol 
dimension. BAT mitochondria were suspended to 1 mg 
protein. ml-‘. 
carefully distinguish between the real inhibitory ef- 
fect and any apparent inhibition caused by 
smoothing of ion gradients due to any disturbed 
membrane permeability by mersalyl. As shown in 
fig.2, mersalyl up to 1.4 mM does not affect 
nigericin-induced swelling of BAT mitochondria in 
K-acetate in the presence of GDP. Therefore, any 
decrease of the initial rate of swelling in K-acetate 
indicates the net inhibition of H+ transport via 
UP. This is valid also for the case of H+ extrusion 
in K2SO4 (not shown). 
Apparent inhibitory constants (Ki) derived from 
linearized mersalyl titration on a logarithmic scale 
(fig.2) are 55 and 67 PM for H+ extrusion in K2S04 
or swelling in K-acetate, respectively. When the Ki 
was calculated as 10ln~‘u~l (where nu is the Hill 
coefficient and a0 is the intercept at the ordinate 
derived from a linearized Hill plot), the results 
were similar. When Hill plots were drawn for 
vo + SD or vo - SD values, the limiting intervals 
for Ki obtained by the above described calculations 
were (38-59pM) for H+ extrusion in K2SO4 and 
(56-82 PM) for swelling in K-acetate. The mean nu 
was 1.39 for H+ extrusion and 0.9 for swelling. 
The faster approach to zero activity in the case of 
K2S04 could be due to different reactivity of mer- 
salyl in these different ionic surroundings but still 
the Ki values of inhibition in K-acetate and K2SO4 
are quite similar. 
When H+ transport via UP was tested as 
valinomycin-induced H+ extrusion in 150 mM KC1 
simultaneously with swelling, reflecting in this case 
Table 1 
The effect of mersalyl on H+ and Cl- transport via the uncoupling protein and on transport 
mediated by added ionophores 
Conditions 
UP-mediated transport 
Transport independent 
of protein carriers 
Remaining activities in the presence of 
210 nmol mersalyl 420 nmol mersalyl 
(mg protein))’ (mg protein)-’ 
(A) valinomycin-induced 
H+ extrusion in KC1 50 f 8 (6) 32 1?1 9 (9) 
(B) valinomycin-induced 
swelling in KC1 80 + 13 (6) 89 + 20 (9) 
(C) nigericin-induced 
H+ extrusion in KC1 + 
GDP 83 f 8 (4) 109 f 20 (4) 
(D) TBT-valinomycin- 
mediated swelling in 
KC1 + GDP + CCCP 80 k 8 (4) 81k l(2) 
Mean values f SD (n experiments) are presented. Significant differences were found to be for 
A vs B at 210 nmol (P < 0.01) and at 420 nmol (P < 0.001). B vs D and B vs C are not 
significantly different 
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Cl- transport via UP [l 1,18,29], some difficulties 
arose due to a more intensive side effect of mer- 
salyl. As shown in table 1, mersalyl at 
210 nmol.(mg protein)-’ slightly decreases also 
the nigericin-induced H+ extrusion in the presence 
of GDP and also the swelling mediated by TBT. 
The decrease in UP-mediated swelling is not 
significantly different from the decreases in ar- 
tificial transport systems, while the decrease in in- 
itial rates of H+ extrusion in KC1 is indeed 
significantly different (table 1). However, a further 
increase of mersalyl concentration to 1 mM leads 
to real membrane damage and to a swollen state of 
mitochondria. This confirms the earlier finding 
that organomercurials induce Cl- permeability 
[27] which, in parallel with increased K+ 
permeability [26,27], results in swelling without 
valinomycin. This strong side effect of mersalyl 
apparent only in KC1 could result from the forma- 
tion of mersalyl-Cl; complexes [30]. 
All these results suggest hat mersalyl specifical- 
ly inhibits H+ transport but not Cl- transport via 
UP. It further supports the suggestion of two in- 
dependent ransport pathways (H+ and Cl- chan- 
nels) in the functional dimeric unit of UP [l 11. 
In order to characterize the environment of the 
SH-group(s) found to be essential for H+ 
translocation via UP, the inhibitory ability of 
various SH-reagents was further studied (table 2). 
Thus PMB exhibits an analogous inhibitory effi- 
ciency to mersalyl and covalently modifying SH- 
reagents DTNB and thiolyte DB also inhibit H+ 
transport via UP (table 2). On the other hand, SH- 
reagents of NEM type, such as NEM and EMA, do 
not affect transport via UP (table 2). The lack of 
the effect by these hydrophobic reagents upports 
the possible localization of the attacked SH- 
group(s) in the hydrophilic environment. 
Therefore, this SH-group should be accessible to 
H+ from the water and could serve as one of the 
H+ binding sites of the H+ transport pathway. 
The sequence of the UP subunit contains 7 Cys, 
hence 14 SH-groups are present in the naturally oc- 
curring dimer [12,13]. According to Aquila’s [12] 
model of UP folding in the membrane obtained on 
the basis of hydropathy, the only SH-group ex- 
posed to the cytosolic water environment should be 
Cys-304. But at present, it is not possible to iden- 
tify the critical SH-group with certainty. 
The finding of the essential SH-group for H+ 
92 
Table 2 
Inhibition of H+ transport via UP by various SH- 
reagents 
SH-reagent Concentration Method Remaining 
@mol. (mg activity 
protein)-‘) (O/o control) 
PMB 82 A 57.7 * 1.7 
(3) 
DTNB 500 A 69 k 6 
(4) 
B 42 + 3 
(2) 
Thiolyte DB 200 A 69 +13 
(2) 
B 52 
EMA 200 B 108 k 14 
(3) 
NEM 200 A 110 f 8 
(2) 
Mean values + SE are presented (n experiments). (A) 
Swelling in K-acetate; (B) H+ extrusion in KCl. PMB 
was added directly to the medium 20 s before 
valinomycin. BAT mitochondria (4.7 mg protein. ml-‘) 
were incubated with DTNB in 236 mM sucrose, 
16.5 mM Tris-Cl (pH &I), 0.9 mM EDTA for 90 min at 
20°C under vigorous stirring. For transport 
measurements aliquots of treated mitochondria were 
added to media without buffer. Thus 3.5 mM Tris-Cl 
(pH readjusted to 7) was present. H+ extrusion was then 
measured at 2 mg protein.ml-‘. Thiolyte DB was 
incubated with mitochondria (5 mg protein.ml-‘) in 
250 mM sucrose, 1 mM EDTA (pH 6.9) for 60 min at 
20°C. EMA and NEM treatment was analogous (20 min 
at O’C) and the reaction was stopped by the addition of 
dithioerythritol. All measurements were performed as in 
the case of DTNB. Control samples were incubated with 
appropriate aliquots of solvents (ethanol or 
dimethylsulfoxide) under the same conditions. No 
treatment decreased initial rate of the transport 
independent of protein carriers more than to 90% of 
activity in control samples 
translocation leads to a consideration of the 
Robillard and Konings model [3 l] of ion transloca- 
tion in UP. It also relates this protein to the large 
family of mitochondrial translocators possessing 
essential SH-groups [22-241. 
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